Sandoz Unit To Pay $3.5M In False Claims Act Deal
Sandoz Inc. subsidiary Eon Labs Inc. has agreed to pay $3.5 million to settle a False Claims Act case alleging it misrepresented its heart drug Nitroglycerin SR as eligible for Medicaid...To view the full article, register now.
Already a subscriber? Click here to view full article